{"id":81089,"date":"2025-03-31T14:35:29","date_gmt":"2025-03-31T14:35:29","guid":{"rendered":"https:\/\/www.cofb.org\/?p=81089"},"modified":"2025-03-31T14:54:28","modified_gmt":"2025-03-31T14:54:28","slug":"formular-i-dispensar-cannabis-medicinal-ala-farmacia-comunitaria-clau-per-a-un-millor-seguiment-farmacoterapeutic-del-pacient","status":"publish","type":"post","link":"https:\/\/www.cofb.org\/ca\/2025\/03\/31\/formular-i-dispensar-cannabis-medicinal-ala-farmacia-comunitaria-clau-per-a-un-millor-seguiment-farmacoterapeutic-del-pacient\/","title":{"rendered":"Formular i dispensar c\u00e0nnabis medicinal a la farm\u00e0cia comunit\u00e0ria, clau per a un millor seguiment farmacoterap\u00e8utic del pacient"},"content":{"rendered":"\n<ul class=\"wp-block-list\">\n<li>El Reial decret per regular el c\u00e0nnabis medicinal a Espanya est\u00e0 actualment en proc\u00e9s de revisi\u00f3 per la UE, i es preveu la seva publicaci\u00f3 al juny o juliol de 2025<\/li>\n\n\n\n<li>Es calcula que 4,5 milions d&#8217;espanyols viuen amb dolor cr\u00f2nic neurop\u00e0tic, la qual cosa suposa un total del 9,2% de la poblaci\u00f3<\/li>\n\n\n\n<li>El farmac\u00e8utic \u00e9s un punt diferencial en la dosificaci\u00f3, el seguiment i l&#8217;orientaci\u00f3 del c\u00e0nnabis medicinal per als pacients<\/li>\n<\/ul>\n\n\n\n<figure class=\"wp-block-image size-large\"><a href=\"https:\/\/www.cofb.org\/wp-content\/uploads\/2025\/03\/COFB_INFARMA_CANNABIS-MEDICINAL_31032025.jpg\" target=\"_blank\" rel=\"noreferrer noopener\"><img fetchpriority=\"high\" decoding=\"async\" width=\"1024\" height=\"683\" src=\"https:\/\/www.cofb.org\/wp-content\/uploads\/2025\/03\/COFB_INFARMA_CANNABIS-MEDICINAL_31032025-1024x683.jpg\" alt=\"\" class=\"wp-image-81090\" srcset=\"https:\/\/www.cofb.org\/wp-content\/uploads\/2025\/03\/COFB_INFARMA_CANNABIS-MEDICINAL_31032025-1024x683.jpg 1024w, https:\/\/www.cofb.org\/wp-content\/uploads\/2025\/03\/COFB_INFARMA_CANNABIS-MEDICINAL_31032025-300x200.jpg 300w, https:\/\/www.cofb.org\/wp-content\/uploads\/2025\/03\/COFB_INFARMA_CANNABIS-MEDICINAL_31032025-768x512.jpg 768w, https:\/\/www.cofb.org\/wp-content\/uploads\/2025\/03\/COFB_INFARMA_CANNABIS-MEDICINAL_31032025-1536x1024.jpg 1536w, https:\/\/www.cofb.org\/wp-content\/uploads\/2025\/03\/COFB_INFARMA_CANNABIS-MEDICINAL_31032025-2048x1366.jpg 2048w, https:\/\/www.cofb.org\/wp-content\/uploads\/2025\/03\/COFB_INFARMA_CANNABIS-MEDICINAL_31032025-18x12.jpg 18w\" sizes=\"(max-width: 1024px) 100vw, 1024px\" \/><\/a><figcaption class=\"wp-element-caption\">D&#8217;esquerra a dreta: Eduardo L\u00f3pez, Javier Miravete, Josep Allu\u00e9, Jes\u00fas de Santiago i Elena Manso.<\/figcaption><\/figure>\n\n\n\n<p><em>Barcelona, 31 de mar\u00e7 de 2025. \u2013 <\/em>Informar-se, consultar i regular \u00e9s clau per a entendre l&#8217;estat d&#8217;opini\u00f3 dels diferents espais que ocupa qualsevol medicament. La confer\u00e8ncia <strong>\u2018Proposada de regulaci\u00f3 del c\u00e0nnabis: qu\u00e8 cal saber?\u2019<\/strong> celebrada en el marc d&#8217;<a href=\"https:\/\/www.infarma.es\/\" target=\"_blank\" rel=\"noreferrer noopener\">Infarma Barcelona 2025<\/a>, ha abordat aquestes q\u00fcestions en relaci\u00f3 amb la <strong>regulaci\u00f3 d&#8217;aquesta planta amb finalitats terap\u00e8utiques.<\/strong><\/p>\n\n\n\n<p>El moderador <strong>Josep Allu\u00e9<\/strong>, vocal de plantes medicinals del Col\u00b7legi de Farmac\u00e8utics de Barcelona (COFB), ha explicat que <strong>la regulaci\u00f3 del c\u00e0nnabis medicinal t\u00e9 una llarga hist\u00f2ria:<\/strong> a l&#8217;octubre de 2021 es va demanar al Congr\u00e9s dels Diputats la creaci\u00f3 de la subcomissi\u00f3 per al seu \u00fas. Aquesta subcomissi\u00f3 va elaborar un document al juny de 2022, que ha estat sotm\u00e8s dues vegades a consulta. Actualment, el document es troba en proc\u00e9s de revisi\u00f3 per part de la Uni\u00f3 Europea (UE) i es preveu que s&#8217;aprovi al juny o juliol d&#8217;enguany en forma de Reial decret.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\"><strong>Indicacions del c\u00e0nnabis medicinal per al tractament del dolor<\/strong><\/h2>\n\n\n\n<p><strong>Jes\u00fas de Santiago<\/strong>, director Unidades de Dolor MIVI Can\u00e0ries, especialista en anestesiologia, reanimaci\u00f3 i tractament del dolor, coordinador del GTSED Cannabinoides, ha comentat en la seva intervenci\u00f3 que, segons el posicionament de la Societat Espanyola del Dolor (SET), els <strong>medicaments fets a base de cannabinoides (MdC) <\/strong>es poden utilitzar en <strong>tercera l\u00ednia de tractament per al dolor neurop\u00e0tic cr\u00f2nic<\/strong>. Per a la resta dels tipus de dolor cr\u00f2nics que siguin refractaris a altres tractaments amb m\u00e9s evid\u00e8ncies, es recomana fer un <strong>assaig terap\u00e8utic personalitzat<\/strong>, ha afegit.<\/p>\n\n\n\n<p>De Santiago ha esmentat tamb\u00e9 les indicacions que m\u00e9s han demostrat evid\u00e8ncia dels cannabinoides en el tractament del dolor: <strong>el dolor cr\u00f2nic neurop\u00e0tic, el dolor oncol\u00f2gic, l&#8217;endometriosi i el dolor nocipl\u00e1stico <\/strong>(dolor cr\u00f2nic primari, fibromi\u00e0lgia, entre altres).<\/p>\n\n\n\n<p>D&#8217;altra banda, ha detallat <strong>com afecta el dolor cr\u00f2nic neurop\u00e0tic<\/strong> i quina <strong>quantitat de pacients el pateixen<\/strong>: <strong>\u201cEl 9,2% de la poblaci\u00f3 espanyola presenta dolor neurop\u00e0tic, estem parlant de 4 milions i mig, que pateixen un dolor dif\u00edcil de tractar, a m\u00e9s, gaireb\u00e9 el 50% dels pacients acaben en unitats de dolor cr\u00f2nic\u201d<\/strong>.<\/p>\n\n\n\n<p>En el cas del <strong>c\u00e0nnabis medicinal<\/strong>, es pot prescriure amb finalitats terap\u00e8utiques per part de metges especialistes en dolor, neurologia o Neuro RHB, entre altres. Tal com comenta De Santiago, els pacients poden recollir la seva medicaci\u00f3 en les farm\u00e0cies hospital\u00e0ries, on se&#8217;ls proporciona una f\u00f3rmula magistral amb preparats estandarditzats de c\u00e0nnabis.<\/p>\n\n\n\n<p>De fet, el c\u00e0nnabis \u00e9s una planta molt complexa que presenta prop de 500 principis actius com el cannabinoides: \u201cProbablement, \u00e9s una de les primeres plantes que l&#8217;\u00e9sser hum\u00e0 va conrear\u201d, com b\u00e9 ha explicat <strong>Eduardo L\u00f3pez<\/strong>, cap de secci\u00f3 en el servei de farm\u00e0cia del Hospital Universitario y Polit\u00e9cnico La Fe de Valencia Val\u00e8ncia.<\/p>\n\n\n\n<p>Segons L\u00f3pez, el Reial decret ha vingut a cobrir una necessitat real: <strong>estandarditzar el tipus de producte i la concentraci\u00f3 de principis actius<\/strong>. En aquest sentit, aquest Reial decret <strong>\u00e9s necessari per tres q\u00fcestions: resoldre coneixement cl\u00ednic, normalitzar els preparats i educar als pacients i als professionals sobre el c\u00e0nnabis medicinal.<\/strong><\/p>\n\n\n\n<h2 class=\"wp-block-heading\"><strong>Pacients que consumeixen c\u00e0nnabis medicinal<\/strong><\/h2>\n\n\n\n<p>Des de la seva experi\u00e8ncia, <strong>Javier Miravete<\/strong>, president de la Uni\u00f3n de Pacientes por la Regulaci\u00f3n del Cannabis Medicinal, ha afirmat que \u00e9s necessari compartir la pr\u00e0ctica d&#8217;un pacient que consumeix aquest principi actiu: <strong>\u201cEstem parlant d&#8217;un medicament que cal saber pautar i dosificar perqu\u00e8 ho sapiguem prescriure de la forma adequada amb els pacients\u201d.<\/strong><\/p>\n\n\n\n<p>Miravete ha puntualitzat una opini\u00f3 clau dels pacients que consumeixen c\u00e0nnabis medicinal: <strong>\u201cMolts pacients confien en el farmac\u00e8utic, ja que pot dedicar temps a proporcionar-los tota la informaci\u00f3 sobre el medicament, generant-los m\u00e9s seguretat\u201d<\/strong>.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\"><strong>El paper de l&#8217;oficina de Farm\u00e0cia en la dispensaci\u00f3 d&#8217;estupefaents<\/strong><\/h2>\n\n\n\n<p><strong>Elena Manso<\/strong>, vocal de Formulaci\u00f3 Magistral del Colegio Oficial de Farmac\u00e9uticos de Madrid, ha esmentat que <strong>formular i dispensar en farm\u00e0cia comunit\u00e0ria \u00e9s prioritari per la capil\u00b7laritat, l&#8217;experi\u00e8ncia en la dispensaci\u00f3 d&#8217;estupefaents i la seva formulaci\u00f3, la qualitat i tra\u00e7abilitat del laboratori formulista i el seguiment farmacoterap\u00e8utic per\u00f2, sobretot, pel pacient.<\/strong><\/p>\n\n\n\n<p>Manso ha recalcat que els farmac\u00e8utics elaboren f\u00f3rmules magistrals estupefaents com la morfina, metadona, fentanil, coca\u00efna, ketamina, que es dispensen en la farm\u00e0cia comunit\u00e0ria, per\u00f2 tamb\u00e9 en farm\u00e0cia hospital\u00e0ria: <strong>\u201cM\u00e9s de 300 refer\u00e8ncies distintes d&#8217;estupefaents es poden dispensar en la farm\u00e0cia comunit\u00e0ria\u201d.<\/strong><\/p>\n\n\n\n<p>Les farm\u00e0cies estan dotades de farmac\u00e8utics totalment qualificats, els qui poden realitzar un seguiment farmacoterap\u00e8utic que es pot fer en una oficina de farm\u00e0cia sense cap mena de problema, fent un protocol perfecte amb cada pacient: \u201cPel pacient, per la seva comoditat, perqu\u00e8 \u00e9s igual de segur i ja \u00e9s una actuaci\u00f3 que fem des de les farm\u00e0cies\u201d.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Barcelona, 31 de mar\u00e7 de 2025. \u2013 Informar-se, consultar i regular \u00e9s clau per a entendre l&#8217;estat d&#8217;opini\u00f3 dels diferents espais que ocupa qualsevol medicament. La confer\u00e8ncia \u2018Proposada de regulaci\u00f3 del c\u00e0nnabis: qu\u00e8 cal saber?\u2019 celebrada en el marc d&#8217;Infarma Barcelona 2025, ha abordat aquestes q\u00fcestions en relaci\u00f3 amb la [&hellip;]<\/p>\n","protected":false},"author":3,"featured_media":81090,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"aside","meta":{"_uag_custom_page_level_css":"","site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"default","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"disabled","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"set","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"footnotes":""},"categories":[23,2165,1060],"tags":[393,649,18,19,520,5304,3989,5308,53,68,69,480,28,5047,76,823,5309,4106,267],"class_list":["post-81089","post","type-post","status-publish","format-aside","has-post-thumbnail","hentry","category-destacats","category-infarma","category-notes-premsa","tag-cannabis","tag-cannabis-medicinal","tag-cofb","tag-collegi-de-farmaceutics-de-barcelona","tag-conferencia","tag-conferencia-actualitat","tag-congres-europeu-doficina-de-farmacia","tag-decret","tag-farmaceutics","tag-farmacia","tag-farmacia-comunitaria","tag-farmacia-hospitalaria","tag-infarma","tag-infarma-barcelona-2025","tag-oficina-de-farmacia","tag-regulacio","tag-reial-decret","tag-salo-i-congres-europeu-de-farmacia","tag-seguiment-farmacoterapeutic","post_format-post-format-aside"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v22.4 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Formular i dispensar c\u00e0nnabis medicinal a la farm\u00e0cia comunit\u00e0ria, clau per a un millor seguiment farmacoterap\u00e8utic del pacient - Col\u00b7legi de Farmac\u00e8utics de Barcelona<\/title>\n<meta name=\"description\" content=\"La confer\u00e8ncia \u2018Proposada de regulaci\u00f3 del c\u00e0nnabis: qu\u00e8 cal saber?\u2019 celebrada en el marc d&#039;Infarma Barcelona 2025, ha abordat diferents q\u00fcestions en relaci\u00f3 amb la regulaci\u00f3 d&#039;aquesta planta amb finalitats terap\u00e8utiques.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.cofb.org\/ca\/2025\/03\/31\/formular-i-dispensar-cannabis-medicinal-ala-farmacia-comunitaria-clau-per-a-un-millor-seguiment-farmacoterapeutic-del-pacient\/\" \/>\n<meta property=\"og:locale\" content=\"ca_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Formular i dispensar c\u00e0nnabis medicinal a la farm\u00e0cia comunit\u00e0ria, clau per a un millor seguiment farmacoterap\u00e8utic del pacient - Col\u00b7legi de Farmac\u00e8utics de Barcelona\" \/>\n<meta property=\"og:description\" content=\"La confer\u00e8ncia \u2018Proposada de regulaci\u00f3 del c\u00e0nnabis: qu\u00e8 cal saber?\u2019 celebrada en el marc d&#039;Infarma Barcelona 2025, ha abordat diferents q\u00fcestions en relaci\u00f3 amb la regulaci\u00f3 d&#039;aquesta planta amb finalitats terap\u00e8utiques.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.cofb.org\/ca\/2025\/03\/31\/formular-i-dispensar-cannabis-medicinal-ala-farmacia-comunitaria-clau-per-a-un-millor-seguiment-farmacoterapeutic-del-pacient\/\" \/>\n<meta property=\"og:site_name\" content=\"Col\u00b7legi de Farmac\u00e8utics de Barcelona\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/farmaceuticsbcn\/\" \/>\n<meta property=\"article:published_time\" content=\"2025-03-31T14:35:29+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-03-31T14:54:28+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.cofb.org\/wp-content\/uploads\/2025\/03\/COFB_INFARMA_CANNABIS-MEDICINAL_31032025.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"2362\" \/>\n\t<meta property=\"og:image:height\" content=\"1575\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Berta Mart\u00ednez\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@farmaceuticsbcn\" \/>\n<meta name=\"twitter:site\" content=\"@farmaceuticsbcn\" \/>\n<meta name=\"twitter:label1\" content=\"Escrit per\" \/>\n\t<meta name=\"twitter:data1\" content=\"Berta Mart\u00ednez\" \/>\n\t<meta name=\"twitter:label2\" content=\"Temps estimat de lectura\" \/>\n\t<meta name=\"twitter:data2\" content=\"5 minuts\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/www.cofb.org\/2025\/03\/31\/formular-i-dispensar-cannabis-medicinal-ala-farmacia-comunitaria-clau-per-a-un-millor-seguiment-farmacoterapeutic-del-pacient\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/www.cofb.org\/2025\/03\/31\/formular-i-dispensar-cannabis-medicinal-ala-farmacia-comunitaria-clau-per-a-un-millor-seguiment-farmacoterapeutic-del-pacient\/\"},\"author\":{\"name\":\"Berta Mart\u00ednez\",\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/person\/f32de3b41b812c85ff923cb4cc849063\"},\"headline\":\"Formular i dispensar c\u00e0nnabis medicinal a la farm\u00e0cia comunit\u00e0ria, clau per a un millor seguiment farmacoterap\u00e8utic del pacient\",\"datePublished\":\"2025-03-31T14:35:29+00:00\",\"dateModified\":\"2025-03-31T14:54:28+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/www.cofb.org\/2025\/03\/31\/formular-i-dispensar-cannabis-medicinal-ala-farmacia-comunitaria-clau-per-a-un-millor-seguiment-farmacoterapeutic-del-pacient\/\"},\"wordCount\":956,\"publisher\":{\"@id\":\"https:\/\/www.cofb.org\/#organization\"},\"image\":{\"@id\":\"https:\/\/www.cofb.org\/2025\/03\/31\/formular-i-dispensar-cannabis-medicinal-ala-farmacia-comunitaria-clau-per-a-un-millor-seguiment-farmacoterapeutic-del-pacient\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.cofb.org\/wp-content\/uploads\/2025\/03\/COFB_INFARMA_CANNABIS-MEDICINAL_31032025.jpg\",\"keywords\":[\"c\u00e0nnabis\",\"cannabis medicinal\",\"COFB\",\"Col\u00b7legi de Farmac\u00e8utics de Barcelona\",\"confer\u00e8ncia\",\"confer\u00e8ncia actualitat\",\"Congr\u00e9s europeu d'oficina de farm\u00e0cia\",\"Decret\",\"farmac\u00e8utics\",\"Farm\u00e0cia\",\"farm\u00e0cia comunit\u00e0ria\",\"farm\u00e0cia hospital\u00e0ria\",\"Infarma\",\"Infarma Barcelona 2025\",\"Oficina de farm\u00e0cia\",\"regulaci\u00f3\",\"Reial decret\",\"Sal\u00f3 i Congr\u00e9s Europeu de Farm\u00e0cia\",\"seguiment farmacoterap\u00e8utic\"],\"articleSection\":[\"Destacats\",\"Infarma\",\"Notes de premsa\"],\"inLanguage\":\"ca\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.cofb.org\/2025\/03\/31\/formular-i-dispensar-cannabis-medicinal-ala-farmacia-comunitaria-clau-per-a-un-millor-seguiment-farmacoterapeutic-del-pacient\/\",\"url\":\"https:\/\/www.cofb.org\/2025\/03\/31\/formular-i-dispensar-cannabis-medicinal-ala-farmacia-comunitaria-clau-per-a-un-millor-seguiment-farmacoterapeutic-del-pacient\/\",\"name\":\"Formular i dispensar c\u00e0nnabis medicinal a la farm\u00e0cia comunit\u00e0ria, clau per a un millor seguiment farmacoterap\u00e8utic del pacient - Col\u00b7legi de Farmac\u00e8utics de Barcelona\",\"isPartOf\":{\"@id\":\"https:\/\/www.cofb.org\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.cofb.org\/2025\/03\/31\/formular-i-dispensar-cannabis-medicinal-ala-farmacia-comunitaria-clau-per-a-un-millor-seguiment-farmacoterapeutic-del-pacient\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.cofb.org\/2025\/03\/31\/formular-i-dispensar-cannabis-medicinal-ala-farmacia-comunitaria-clau-per-a-un-millor-seguiment-farmacoterapeutic-del-pacient\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.cofb.org\/wp-content\/uploads\/2025\/03\/COFB_INFARMA_CANNABIS-MEDICINAL_31032025.jpg\",\"datePublished\":\"2025-03-31T14:35:29+00:00\",\"dateModified\":\"2025-03-31T14:54:28+00:00\",\"description\":\"La confer\u00e8ncia \u2018Proposada de regulaci\u00f3 del c\u00e0nnabis: qu\u00e8 cal saber?\u2019 celebrada en el marc d'Infarma Barcelona 2025, ha abordat diferents q\u00fcestions en relaci\u00f3 amb la regulaci\u00f3 d'aquesta planta amb finalitats terap\u00e8utiques.\",\"breadcrumb\":{\"@id\":\"https:\/\/www.cofb.org\/2025\/03\/31\/formular-i-dispensar-cannabis-medicinal-ala-farmacia-comunitaria-clau-per-a-un-millor-seguiment-farmacoterapeutic-del-pacient\/#breadcrumb\"},\"inLanguage\":\"ca\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.cofb.org\/2025\/03\/31\/formular-i-dispensar-cannabis-medicinal-ala-farmacia-comunitaria-clau-per-a-un-millor-seguiment-farmacoterapeutic-del-pacient\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"ca\",\"@id\":\"https:\/\/www.cofb.org\/2025\/03\/31\/formular-i-dispensar-cannabis-medicinal-ala-farmacia-comunitaria-clau-per-a-un-millor-seguiment-farmacoterapeutic-del-pacient\/#primaryimage\",\"url\":\"https:\/\/www.cofb.org\/wp-content\/uploads\/2025\/03\/COFB_INFARMA_CANNABIS-MEDICINAL_31032025.jpg\",\"contentUrl\":\"https:\/\/www.cofb.org\/wp-content\/uploads\/2025\/03\/COFB_INFARMA_CANNABIS-MEDICINAL_31032025.jpg\",\"width\":2362,\"height\":1575,\"caption\":\"D'esquerra a dreta: Eduardo L\u00f3pez, Javier Miravete, Josep Allu\u00e9, Jes\u00fas de Santiago i Elena Manso.\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.cofb.org\/2025\/03\/31\/formular-i-dispensar-cannabis-medicinal-ala-farmacia-comunitaria-clau-per-a-un-millor-seguiment-farmacoterapeutic-del-pacient\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Inici\",\"item\":\"https:\/\/novaorg.cofb.net\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Formular i dispensar c\u00e0nnabis medicinal a la farm\u00e0cia comunit\u00e0ria, clau per a un millor seguiment farmacoterap\u00e8utic del pacient\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.cofb.org\/#website\",\"url\":\"https:\/\/www.cofb.org\/\",\"name\":\"Col\u00b7legi de Farmac\u00e8utics de Barcelona\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\/\/www.cofb.org\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.cofb.org\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"ca\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.cofb.org\/#organization\",\"name\":\"Col\u00b7legi de Farmac\u00e8utics de Barcelona\",\"url\":\"https:\/\/www.cofb.org\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"ca\",\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/11\/cropped-Logotip-COFB.png\",\"contentUrl\":\"https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/11\/cropped-Logotip-COFB.png\",\"width\":500,\"height\":105,\"caption\":\"Col\u00b7legi de Farmac\u00e8utics de Barcelona\"},\"image\":{\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/farmaceuticsbcn\/\",\"https:\/\/twitter.com\/farmaceuticsbcn\",\"https:\/\/www.instagram.com\/farmaceuticsbcn\/\",\"https:\/\/www.linkedin.com\/company\/farmaceuticsbcn\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/person\/f32de3b41b812c85ff923cb4cc849063\",\"name\":\"Berta Mart\u00ednez\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"ca\",\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/d4c584dab5da1ee9e3c3df161c0aabec7075cc8211cd46ffc79bfe177aa78b01?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/d4c584dab5da1ee9e3c3df161c0aabec7075cc8211cd46ffc79bfe177aa78b01?s=96&d=mm&r=g\",\"caption\":\"Berta Mart\u00ednez\"},\"url\":\"https:\/\/www.cofb.org\/ca\/author\/bmartinez\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Formular i dispensar c\u00e0nnabis medicinal a la farm\u00e0cia comunit\u00e0ria, clau per a un millor seguiment farmacoterap\u00e8utic del pacient - Col\u00b7legi de Farmac\u00e8utics de Barcelona","description":"La confer\u00e8ncia \u2018Proposada de regulaci\u00f3 del c\u00e0nnabis: qu\u00e8 cal saber?\u2019 celebrada en el marc d'Infarma Barcelona 2025, ha abordat diferents q\u00fcestions en relaci\u00f3 amb la regulaci\u00f3 d'aquesta planta amb finalitats terap\u00e8utiques.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.cofb.org\/ca\/2025\/03\/31\/formular-i-dispensar-cannabis-medicinal-ala-farmacia-comunitaria-clau-per-a-un-millor-seguiment-farmacoterapeutic-del-pacient\/","og_locale":"ca_ES","og_type":"article","og_title":"Formular i dispensar c\u00e0nnabis medicinal a la farm\u00e0cia comunit\u00e0ria, clau per a un millor seguiment farmacoterap\u00e8utic del pacient - Col\u00b7legi de Farmac\u00e8utics de Barcelona","og_description":"La confer\u00e8ncia \u2018Proposada de regulaci\u00f3 del c\u00e0nnabis: qu\u00e8 cal saber?\u2019 celebrada en el marc d'Infarma Barcelona 2025, ha abordat diferents q\u00fcestions en relaci\u00f3 amb la regulaci\u00f3 d'aquesta planta amb finalitats terap\u00e8utiques.","og_url":"https:\/\/www.cofb.org\/ca\/2025\/03\/31\/formular-i-dispensar-cannabis-medicinal-ala-farmacia-comunitaria-clau-per-a-un-millor-seguiment-farmacoterapeutic-del-pacient\/","og_site_name":"Col\u00b7legi de Farmac\u00e8utics de Barcelona","article_publisher":"https:\/\/www.facebook.com\/farmaceuticsbcn\/","article_published_time":"2025-03-31T14:35:29+00:00","article_modified_time":"2025-03-31T14:54:28+00:00","og_image":[{"width":2362,"height":1575,"url":"https:\/\/www.cofb.org\/wp-content\/uploads\/2025\/03\/COFB_INFARMA_CANNABIS-MEDICINAL_31032025.jpg","type":"image\/jpeg"}],"author":"Berta Mart\u00ednez","twitter_card":"summary_large_image","twitter_creator":"@farmaceuticsbcn","twitter_site":"@farmaceuticsbcn","twitter_misc":{"Escrit per":"Berta Mart\u00ednez","Temps estimat de lectura":"5 minuts"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.cofb.org\/2025\/03\/31\/formular-i-dispensar-cannabis-medicinal-ala-farmacia-comunitaria-clau-per-a-un-millor-seguiment-farmacoterapeutic-del-pacient\/#article","isPartOf":{"@id":"https:\/\/www.cofb.org\/2025\/03\/31\/formular-i-dispensar-cannabis-medicinal-ala-farmacia-comunitaria-clau-per-a-un-millor-seguiment-farmacoterapeutic-del-pacient\/"},"author":{"name":"Berta Mart\u00ednez","@id":"https:\/\/www.cofb.org\/#\/schema\/person\/f32de3b41b812c85ff923cb4cc849063"},"headline":"Formular i dispensar c\u00e0nnabis medicinal a la farm\u00e0cia comunit\u00e0ria, clau per a un millor seguiment farmacoterap\u00e8utic del pacient","datePublished":"2025-03-31T14:35:29+00:00","dateModified":"2025-03-31T14:54:28+00:00","mainEntityOfPage":{"@id":"https:\/\/www.cofb.org\/2025\/03\/31\/formular-i-dispensar-cannabis-medicinal-ala-farmacia-comunitaria-clau-per-a-un-millor-seguiment-farmacoterapeutic-del-pacient\/"},"wordCount":956,"publisher":{"@id":"https:\/\/www.cofb.org\/#organization"},"image":{"@id":"https:\/\/www.cofb.org\/2025\/03\/31\/formular-i-dispensar-cannabis-medicinal-ala-farmacia-comunitaria-clau-per-a-un-millor-seguiment-farmacoterapeutic-del-pacient\/#primaryimage"},"thumbnailUrl":"https:\/\/www.cofb.org\/wp-content\/uploads\/2025\/03\/COFB_INFARMA_CANNABIS-MEDICINAL_31032025.jpg","keywords":["c\u00e0nnabis","cannabis medicinal","COFB","Col\u00b7legi de Farmac\u00e8utics de Barcelona","confer\u00e8ncia","confer\u00e8ncia actualitat","Congr\u00e9s europeu d'oficina de farm\u00e0cia","Decret","farmac\u00e8utics","Farm\u00e0cia","farm\u00e0cia comunit\u00e0ria","farm\u00e0cia hospital\u00e0ria","Infarma","Infarma Barcelona 2025","Oficina de farm\u00e0cia","regulaci\u00f3","Reial decret","Sal\u00f3 i Congr\u00e9s Europeu de Farm\u00e0cia","seguiment farmacoterap\u00e8utic"],"articleSection":["Destacats","Infarma","Notes de premsa"],"inLanguage":"ca"},{"@type":"WebPage","@id":"https:\/\/www.cofb.org\/2025\/03\/31\/formular-i-dispensar-cannabis-medicinal-ala-farmacia-comunitaria-clau-per-a-un-millor-seguiment-farmacoterapeutic-del-pacient\/","url":"https:\/\/www.cofb.org\/2025\/03\/31\/formular-i-dispensar-cannabis-medicinal-ala-farmacia-comunitaria-clau-per-a-un-millor-seguiment-farmacoterapeutic-del-pacient\/","name":"Formular i dispensar c\u00e0nnabis medicinal a la farm\u00e0cia comunit\u00e0ria, clau per a un millor seguiment farmacoterap\u00e8utic del pacient - Col\u00b7legi de Farmac\u00e8utics de Barcelona","isPartOf":{"@id":"https:\/\/www.cofb.org\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.cofb.org\/2025\/03\/31\/formular-i-dispensar-cannabis-medicinal-ala-farmacia-comunitaria-clau-per-a-un-millor-seguiment-farmacoterapeutic-del-pacient\/#primaryimage"},"image":{"@id":"https:\/\/www.cofb.org\/2025\/03\/31\/formular-i-dispensar-cannabis-medicinal-ala-farmacia-comunitaria-clau-per-a-un-millor-seguiment-farmacoterapeutic-del-pacient\/#primaryimage"},"thumbnailUrl":"https:\/\/www.cofb.org\/wp-content\/uploads\/2025\/03\/COFB_INFARMA_CANNABIS-MEDICINAL_31032025.jpg","datePublished":"2025-03-31T14:35:29+00:00","dateModified":"2025-03-31T14:54:28+00:00","description":"La confer\u00e8ncia \u2018Proposada de regulaci\u00f3 del c\u00e0nnabis: qu\u00e8 cal saber?\u2019 celebrada en el marc d'Infarma Barcelona 2025, ha abordat diferents q\u00fcestions en relaci\u00f3 amb la regulaci\u00f3 d'aquesta planta amb finalitats terap\u00e8utiques.","breadcrumb":{"@id":"https:\/\/www.cofb.org\/2025\/03\/31\/formular-i-dispensar-cannabis-medicinal-ala-farmacia-comunitaria-clau-per-a-un-millor-seguiment-farmacoterapeutic-del-pacient\/#breadcrumb"},"inLanguage":"ca","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.cofb.org\/2025\/03\/31\/formular-i-dispensar-cannabis-medicinal-ala-farmacia-comunitaria-clau-per-a-un-millor-seguiment-farmacoterapeutic-del-pacient\/"]}]},{"@type":"ImageObject","inLanguage":"ca","@id":"https:\/\/www.cofb.org\/2025\/03\/31\/formular-i-dispensar-cannabis-medicinal-ala-farmacia-comunitaria-clau-per-a-un-millor-seguiment-farmacoterapeutic-del-pacient\/#primaryimage","url":"https:\/\/www.cofb.org\/wp-content\/uploads\/2025\/03\/COFB_INFARMA_CANNABIS-MEDICINAL_31032025.jpg","contentUrl":"https:\/\/www.cofb.org\/wp-content\/uploads\/2025\/03\/COFB_INFARMA_CANNABIS-MEDICINAL_31032025.jpg","width":2362,"height":1575,"caption":"D'esquerra a dreta: Eduardo L\u00f3pez, Javier Miravete, Josep Allu\u00e9, Jes\u00fas de Santiago i Elena Manso."},{"@type":"BreadcrumbList","@id":"https:\/\/www.cofb.org\/2025\/03\/31\/formular-i-dispensar-cannabis-medicinal-ala-farmacia-comunitaria-clau-per-a-un-millor-seguiment-farmacoterapeutic-del-pacient\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Inici","item":"https:\/\/novaorg.cofb.net\/"},{"@type":"ListItem","position":2,"name":"Formular i dispensar c\u00e0nnabis medicinal a la farm\u00e0cia comunit\u00e0ria, clau per a un millor seguiment farmacoterap\u00e8utic del pacient"}]},{"@type":"WebSite","@id":"https:\/\/www.cofb.org\/#website","url":"https:\/\/www.cofb.org\/","name":"Col\u00b7legi de Farmac\u00e8utics de Barcelona","description":"","publisher":{"@id":"https:\/\/www.cofb.org\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.cofb.org\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"ca"},{"@type":"Organization","@id":"https:\/\/www.cofb.org\/#organization","name":"Col\u00b7legi de Farmac\u00e8utics de Barcelona","url":"https:\/\/www.cofb.org\/","logo":{"@type":"ImageObject","inLanguage":"ca","@id":"https:\/\/www.cofb.org\/#\/schema\/logo\/image\/","url":"https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/11\/cropped-Logotip-COFB.png","contentUrl":"https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/11\/cropped-Logotip-COFB.png","width":500,"height":105,"caption":"Col\u00b7legi de Farmac\u00e8utics de Barcelona"},"image":{"@id":"https:\/\/www.cofb.org\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/farmaceuticsbcn\/","https:\/\/twitter.com\/farmaceuticsbcn","https:\/\/www.instagram.com\/farmaceuticsbcn\/","https:\/\/www.linkedin.com\/company\/farmaceuticsbcn\/"]},{"@type":"Person","@id":"https:\/\/www.cofb.org\/#\/schema\/person\/f32de3b41b812c85ff923cb4cc849063","name":"Berta Mart\u00ednez","image":{"@type":"ImageObject","inLanguage":"ca","@id":"https:\/\/www.cofb.org\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/d4c584dab5da1ee9e3c3df161c0aabec7075cc8211cd46ffc79bfe177aa78b01?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/d4c584dab5da1ee9e3c3df161c0aabec7075cc8211cd46ffc79bfe177aa78b01?s=96&d=mm&r=g","caption":"Berta Mart\u00ednez"},"url":"https:\/\/www.cofb.org\/ca\/author\/bmartinez\/"}]}},"uagb_featured_image_src":{"full":["https:\/\/www.cofb.org\/wp-content\/uploads\/2025\/03\/COFB_INFARMA_CANNABIS-MEDICINAL_31032025.jpg",2362,1575,false],"thumbnail":["https:\/\/www.cofb.org\/wp-content\/uploads\/2025\/03\/COFB_INFARMA_CANNABIS-MEDICINAL_31032025-150x150.jpg",150,150,true],"medium":["https:\/\/www.cofb.org\/wp-content\/uploads\/2025\/03\/COFB_INFARMA_CANNABIS-MEDICINAL_31032025-300x200.jpg",300,200,true],"medium_large":["https:\/\/www.cofb.org\/wp-content\/uploads\/2025\/03\/COFB_INFARMA_CANNABIS-MEDICINAL_31032025-768x512.jpg",768,512,true],"large":["https:\/\/www.cofb.org\/wp-content\/uploads\/2025\/03\/COFB_INFARMA_CANNABIS-MEDICINAL_31032025-1024x683.jpg",1024,683,true],"1536x1536":["https:\/\/www.cofb.org\/wp-content\/uploads\/2025\/03\/COFB_INFARMA_CANNABIS-MEDICINAL_31032025-1536x1024.jpg",1536,1024,true],"2048x2048":["https:\/\/www.cofb.org\/wp-content\/uploads\/2025\/03\/COFB_INFARMA_CANNABIS-MEDICINAL_31032025-2048x1366.jpg",2048,1366,true],"trp-custom-language-flag":["https:\/\/www.cofb.org\/wp-content\/uploads\/2025\/03\/COFB_INFARMA_CANNABIS-MEDICINAL_31032025-18x12.jpg",18,12,true]},"uagb_author_info":{"display_name":"Berta Mart\u00ednez","author_link":"https:\/\/www.cofb.org\/ca\/author\/bmartinez\/"},"uagb_comment_info":0,"uagb_excerpt":"Barcelona, 31 de mar\u00e7 de 2025. \u2013 Informar-se, consultar i regular \u00e9s clau per a entendre l&#8217;estat d&#8217;opini\u00f3 dels diferents espais que ocupa qualsevol medicament. La confer\u00e8ncia \u2018Proposada de regulaci\u00f3 del c\u00e0nnabis: qu\u00e8 cal saber?\u2019 celebrada en el marc d&#8217;Infarma Barcelona 2025, ha abordat aquestes q\u00fcestions en relaci\u00f3 amb la [&hellip;]","_links":{"self":[{"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/posts\/81089","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/comments?post=81089"}],"version-history":[{"count":6,"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/posts\/81089\/revisions"}],"predecessor-version":[{"id":81096,"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/posts\/81089\/revisions\/81096"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/media\/81090"}],"wp:attachment":[{"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/media?parent=81089"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/categories?post=81089"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/tags?post=81089"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}